Advertisement
Advertisement
MNKD
Mannkind Corporation
3.21
USDSponsored
-0.07
-2.13%
May 13, 16:00 UTC -4
Closed
After-Market
3.24
+0.03
+0.93%
MNKD Earnings Reports
Positive Surprise Ratio
MNKD beat 18 of 42 last estimates.
43%
Next Report
Date of Next Report
Aug 04, 2026
Estimate for Q2 26 (Revenue/ EPS)
$111.45M
/$0.00
Implied change from Q1 26 (Revenue/ EPS)
+23.60%
/-100.00%
Implied change from Q2 25 (Revenue/ EPS)
+45.64%
/--
Mannkind Corporation earnings per share and revenue
On May 06, 2026, MNKD reported earnings of -0.05 USD per share (EPS) for Q1 26, missing the estimate of 0.00 USD, resulting in a -3233.33% surprise. Revenue reached 90.17 million, compared to an expected 108.69 million, with a -17.04% difference. The market reacted with a -0.28% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 6 analysts forecast an EPS of 0.00 USD, with revenue projected to reach 111.45 million USD, implying an decrease of -100.00% EPS, and increase of 23.60% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Kamada Ltd
Report Date
May 13, 2026 For Q1 26
Estimate
$0.11
Actual
$0.07
Surprise
-40.32%
Abeona Therapeutics Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.36
Actual
-$0.30
Surprise
+17.31%
Milestone Pharmaceuticals Inc. Common Shares
Report Date
May 13, 2026 For Q1 26
Estimate
$0.31
Actual
-$0.20
Surprise
-163.94%
Spero Therapeutics, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.18
Actual
-$0.13
Surprise
+29.19%
Equillium, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.04
Actual
-$0.06
Surprise
-34.53%
Spruce Biosciences, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$8.99
Actual
-$8.94
Surprise
+0.58%
BeyondSpring Inc. Ordinary Shares
Report Date
May 13, 2026 For Q1 26
Estimate
-Actual
-$0.05
Surprise
-
Tango Therapeutics, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.31
Actual
-$0.32
Surprise
-0.13%
Longeveron Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.16
Actual
-$0.19
Surprise
-12.89%
Bionano Genomics, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.96
Actual
-$0.76
Surprise
+21.57%
FAQ
What were Mannkind Corporation's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Mannkind Corporation reported EPS of -$0.05, missing estimates by -3233.33%, and revenue of $90.17M, -17.04% below expectations.
How did the market react to Mannkind Corporation's Q1 2026 earnings?
The stock price moved down -0.28%, changed from $3.56 before the earnings release to $3.55 the day after.
When is Mannkind Corporation expected to report next?
The next earning report is scheduled for Aug 04, 2026.
What are the forecasts for Mannkind Corporation's next earnings report?
Based on 6
analysts, Mannkind Corporation is expected to report EPS of -- and revenue of $111.45M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement